Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of ~$10B, adding treatments for rare hormonal diseases to its portfolio

https://www.reuters.com/legal/transactional/vertex-buy-crinetics-10-billion-deal-2026-07-06/